Vimarsana
Biggest News Aggregation in the World

Big Molecule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Big Molecule. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Big Molecule Today - Breaking & Trending Today

Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR - Patent - Vimarsana News

Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR - Patent

We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, "Moderna") against BioNTech SE, BioNTech Manufacturing GmbH...

Source: mondaq.com
Post-Trial Updates On Regeneron V. Mylan (Aflibercept) BPCIA Litigation - Patent - Vimarsana News

Post-Trial Updates On Regeneron V. Mylan (Aflibercept) BPCIA Litigation - Patent

Appeals from and redacted memorandum and opinion in support of judgment in Regeneron v. Mylan (aflibercept) BPCIA case filed

Source: mondaq.com
Year in Review: Top Legal Developments of 2023 | Goodwin - Vimarsana News

Year in Review: Top Legal Developments of 2023 | Goodwin

​​​​​​​As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. The following is a recap of...

Year In Review: Top Deals In 2023 - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Year In Review: Top Deals In 2023 - Life Sciences, Biotechnology & Nanotechnology

According to PWC, "2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels."

Source: mondaq.com
Year in Review: Top Deals in 2023 | Goodwin - Vimarsana News

Year in Review: Top Deals in 2023 | Goodwin

According to PWC, “2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels.” Below is a...